The Graduate Program in Cellular and Molecular Medicine (CMM) was created in 1993 and offers highly qualified Ph.D. candidates the opportunity to learn the theory and practice of modern cellular and molecular biology while conducting laboratory research on problems with direct clinical relevance. CMM is an independent Graduate Program at the Johns Hopkins School of Medicine with separate admissions, a special curriculum, and is certified to award the degree of Doctor of Philosophy (PhD). Now in its 16th year, CMM matriculates -18-25 incoming students selected from ~200 applicants every year. A total of 98 Students (as of May 2008) have graduated from the Program. CMM faculty members are from clinical departments and basic science departments. They were selected because of their successful independent laboratory programs, NIH funding, and their suitability to serve as mentors for young scientists. Importantly, CMM faculty pursues research at cellular and molecular levels on human diseases including: cancer;cardiopulmonary and vascular disorders;neurobiology and neurological disorders;immunological and infectious diseases;metabolic, developmental, and genetic defects. The goal of CMM is to train young scientists for careers studying human diseases at cellular and molecular levels. We expect that most CMM graduates will take academic positions in medical schools pursuing research in clinical departments, while some may choose to pursue research in industry.
Rapid progress in cellular and molecular biology has strongly impacted on clinical medicine, offering insights about the fundamental causes of many diseases. Now new discoveries in the laboratory can be applied rapidly to the diagnosis, treatment and prevention of disease. The trainees in this program are working precisely at this interface between science and medicine to contribute to the long term well being of society.
| Cohen, Joshua D; Li, Lu; Wang, Yuxuan et al. (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359:926-930 |
| Piard, Juliette; Umanah, George K Essien; Harms, Frederike L et al. (2018) A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy. Brain : |
| Vermillion, Meghan S; Klein, Sabra L (2018) Pregnancy and infection: using disease pathogenesis to inform vaccine strategy. NPJ Vaccines 3:6 |
| Liu, Rui Han; Ong, Chin Siang; Fukunishi, Takuma et al. (2018) Review of Vascular Graft Studies in Large Animal Models. Tissue Eng Part B Rev 24:133-143 |
| Amend, Sarah R; de Groot, Amber E; Torga, Gonzalo et al. (2018) Ten unanswered questions in cancer: ""If this is true, what does it imply""? Am J Clin Exp Urol 6:26-31 |
| Ong, Chin Siang; Nam, Lucy; Ong, Kingsfield et al. (2018) 3D and 4D Bioprinting of the Myocardium: Current Approaches, Challenges, and Future Prospects. Biomed Res Int 2018:6497242 |
| Cravero, Karen; Medford, Arielle; Pallavajjala, Aparna et al. (2018) Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity. Pract Lab Med 12:e00108 |
| Barrington, William T; Wulfridge, Phillip; Wells, Ann E et al. (2018) Improving Metabolic Health Through Precision Dietetics in Mice. Genetics 208:399-417 |
| Vermillion, Meghan S; Nelson, Andrew; Vom Steeg, Landon et al. (2018) Pregnancy preserves pulmonary function following influenza virus infection in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol 315:L517-L525 |
| Porter, Corey M; Shrestha, Eva; Peiffer, Lauren B et al. (2018) The microbiome in prostate inflammation and prostate cancer. Prostate Cancer Prostatic Dis 21:345-354 |
Showing the most recent 10 out of 274 publications
